Zoetis (ZTS) Non-Current Assets (2012 - 2026)
Zoetis (ZTS) reported Non-Current Assets of $8.7 billion for Q1 2026, up 5.58% year-over-year from $8.2 billion in Q1 2025, and little changed quarter-over-quarter from $8.7 billion in Q4 2025.
Zoetis (ZTS) Non-Current Assets (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Non-Current Assets data on file, last reported at $8.7 billion in Q1 2026.
- Non-Current Assets for Q1 2026 came in at $8.7 billion, up 5.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $34.5 billion (up 6.21% YoY), and the FY2025 annual result was $8.7 billion, up 5.65% from the prior year.
- Non-Current Assets held at $8.7 billion in Q1 2026 per ZTS's latest filing, from $8.7 billion in the prior quarter.
- Over five years, Non-Current Assets peaked at $8.7 billion in Q4 2025 and troughed at $7.0 billion in Q1 2022.
- A 5-year average of $7.9 billion and a median of $8.0 billion in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2023: Non-Current Assets advanced 0.3% in 2022, then climbed 10.68% in 2023.
- A 5-year view of Non-Current Assets shows it stood at $7.4 billion in 2022, then advanced by 7.06% to $7.9 billion in 2023, then gained by 3.88% to $8.3 billion in 2024, then increased by 5.65% to $8.7 billion in 2025, then dropped by 0.42% to $8.7 billion in 2026.
- Business Quant data shows ZTS's Non-Current Assets at $8.7 billion in Q1 2026, $8.7 billion in Q4 2025, and $8.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.40 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.22 Bn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 68.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.68 Bn |
| Dec 31, 2025 | 8.72 Bn |
| Sep 30, 2025 | 8.58 Bn |
| Jun 30, 2025 | 8.56 Bn |
| Mar 31, 2025 | 8.22 Bn |
| Dec 31, 2024 | 8.25 Bn |
| Sep 30, 2024 | 8.08 Bn |
| Jun 30, 2024 | 7.96 Bn |
| Mar 31, 2024 | 7.99 Bn |
| Dec 31, 2023 | 7.94 Bn |
| Sep 30, 2023 | 7.88 Bn |
| Jun 30, 2023 | 7.57 Bn |
| Mar 31, 2023 | 7.49 Bn |
| Dec 31, 2022 | 7.42 Bn |
| Sep 30, 2022 | 7.12 Bn |
| Jun 30, 2022 | 7.12 Bn |
| Mar 31, 2022 | 7.02 Bn |
| Dec 31, 2021 | 6.97 Bn |
| Sep 30, 2021 | 7.02 Bn |
| Jun 30, 2021 | 7.02 Bn |